SlideShare ist ein Scribd-Unternehmen logo
1 von 10
PREVELENCE OF CANCER ASSOCIATED GENES IN
 BREAST CANCER PATIENTS IN THE HOSPITAL
   BASED STUDY FROM SOUTHERN ASSAM




                               Presented By

                               Jagadish Hansa
                               Biotechnology dept.



           Assam University,
           Silchar
What is breast cancer ??
Umberto Veronesi said if India does not put in place a vigorous
mechanism for early detection and an awareness building exercise,
then India will have more breast cancer patient as compare to other
part of world in 2020.

                                  Types of undesired cell
                                  growth in breast:-
                                   Fibroadenoma
                                   Cyst
                                   Abscess
                                   Fibrocystic disease
                                   Tumor


                                                            TUMOR
Symptoms of breast cancer
 Change in nipple

 Change in direction of nipple

 Eczematous changes of nipple

 Presence of a lump or thickening

   Persistent discomfort and pain
   Change in nipple discharge
   Change in appearance of moles
FACTORS EFFECTING BREAST
Simply being a woman is the main risk factor for
Developing breast cancer.
Two types:- sporadic and hereditary breast cancer.
Hereditary cancer is by BRCA1 and BRCA2 gene.
Commonest cause of death for woman (35-55yr).



                       Age
                                  Family History
          Genetic
          Factors
                                             Reproductive
                                               History
                           Radiation

       Race                            Menstrual
                Treatment with          History
                     DES
BRCA1 - location
 Localized to the long arm of chromosome 17q21.
 Distributed over 100,000 base pairs of DNA.
 24 exons (22 coding + 2 non-coding) which encode a
  protein that is 1,863 aa in length.
 BRCT (C-terminal of BRCA) domain
   – Consists of 2 conserved BRCT repeats~90-100 amino acids long.
 N-terminal – ring-finger domain where Bard1 protein bind.
BRCA2
 Localized to chromosome 13q12-13.
 27 encoding exons distributed over roughly
  70 kb of genomic DNA.
 The exons encode a known sequence of
  3418 aa length.
 Carriers also have increased risks of
  pancreatic, prostate, laryngeal, and ocular
  cancers.
Normal function!!!
 BRCA 1 and BRCA 2
  – Known as breast and ovarian cancer
    susceptibility genes
  – Tumor suppressor genes
     regulate the cycle of cell division by keeping cells
      from growing and dividing too rapidly or in an
      uncontrolled way
     inhibit the growth of cells that line the milk ducts in
      the breast
  – Involved in many other functions including
    control of DNA replication and damage repair
Abnormal behaviour of BRCA genes
BRCA-1
 Germline mutations within BRCA1 predispose carriers (heterozyg-
  otes) to early onset breast and 80% risk of breast cancer.
 Over 100 different mutations are associated with the BRCA1.
 Three main anomalies account for approx. 19% of the mutations:-
  1) 185delAG in codon 23, 2) 5382insC on codon 1756, 3) 4184del4 in
  codon 1355.
 Mutations found at the 5’ end increased risk of ovarian cancer.


BRCA-2

   BRCA2 mutations confer higher risk of male breast cancer.
   One mutation occur frequently: 6174delT
   Similar statistics for BRCA2 carriers, but later age of onset and
    lead to other tumors: gastric, colon, pancreatic, prostate, and
    melanoma
Thank
 you all
for your
  kind
attention

Weitere ähnliche Inhalte

Was ist angesagt?

Hereditary Cancer Syndrome
Hereditary Cancer SyndromeHereditary Cancer Syndrome
Hereditary Cancer SyndromeSujoy Dasgupta
 
Kimberly Glass, Network model - Ovarian Cancer, fged_seattle_2013
Kimberly Glass, Network model - Ovarian Cancer, fged_seattle_2013Kimberly Glass, Network model - Ovarian Cancer, fged_seattle_2013
Kimberly Glass, Network model - Ovarian Cancer, fged_seattle_2013Functional Genomics Data Society
 
HEREDITARY BREAST and OVARY CANCER [HBOC] SYNDROME, Dr BUI DAC CHI.
HEREDITARY BREAST and OVARY CANCER [HBOC] SYNDROME, Dr BUI DAC CHI.HEREDITARY BREAST and OVARY CANCER [HBOC] SYNDROME, Dr BUI DAC CHI.
HEREDITARY BREAST and OVARY CANCER [HBOC] SYNDROME, Dr BUI DAC CHI.hungnguyenthien
 
Use of Autoantibodies to detect the onset of breast cancer
Use of Autoantibodies to detect the onset of breast cancerUse of Autoantibodies to detect the onset of breast cancer
Use of Autoantibodies to detect the onset of breast cancerIsabelle Chiu
 
Stefano Volinia, miRNA Signature - Breast Cancer, fged_seattle_2013
Stefano Volinia, miRNA Signature - Breast Cancer, fged_seattle_2013Stefano Volinia, miRNA Signature - Breast Cancer, fged_seattle_2013
Stefano Volinia, miRNA Signature - Breast Cancer, fged_seattle_2013Functional Genomics Data Society
 
Prophylaxis and early diagnosis of breast cancer
Prophylaxis and early diagnosis of breast cancerProphylaxis and early diagnosis of breast cancer
Prophylaxis and early diagnosis of breast cancerINVICTA GENETICS
 
Molecular profiling in breast cancer
Molecular profiling in breast cancerMolecular profiling in breast cancer
Molecular profiling in breast cancerShashidhara TS
 
Cancer genetics [autosaved]
Cancer genetics [autosaved]Cancer genetics [autosaved]
Cancer genetics [autosaved]prachiupadhyay8
 
Gene expression profiling in breast carcinoma
Gene expression profiling in breast carcinomaGene expression profiling in breast carcinoma
Gene expression profiling in breast carcinomaghoshparthanrs
 
Molecular profiling in breast cancer
Molecular profiling in breast cancerMolecular profiling in breast cancer
Molecular profiling in breast cancerMebanshanbor Garod
 
Breast Cancer: A focus on BRCA Mutations.
Breast Cancer: A focus on BRCA Mutations.Breast Cancer: A focus on BRCA Mutations.
Breast Cancer: A focus on BRCA Mutations.Mohamed Abdulla
 
Ca breast molecular biology
Ca breast molecular biology Ca breast molecular biology
Ca breast molecular biology suhas k r
 
BRCA – IMPORTANCE IN HEREDITARY BREAST & OVARIAN CANCER by Dr Sharda Jain
BRCA – IMPORTANCE IN HEREDITARY  BREAST & OVARIAN CANCER by Dr Sharda Jain BRCA – IMPORTANCE IN HEREDITARY  BREAST & OVARIAN CANCER by Dr Sharda Jain
BRCA – IMPORTANCE IN HEREDITARY BREAST & OVARIAN CANCER by Dr Sharda Jain Lifecare Centre
 
Brca2 mutation and their influence to cancer
Brca2 mutation and their influence to cancerBrca2 mutation and their influence to cancer
Brca2 mutation and their influence to cancergalinayakubova
 
CCO Rational Options in Breast Cancer : How Molecular Understanding Informs T...
CCO Rational Options in Breast Cancer : How Molecular Understanding Informs T...CCO Rational Options in Breast Cancer : How Molecular Understanding Informs T...
CCO Rational Options in Breast Cancer : How Molecular Understanding Informs T...Adonis Guancia
 
Immuno histo chemistry in gyn oncology
Immuno histo chemistry in gyn oncologyImmuno histo chemistry in gyn oncology
Immuno histo chemistry in gyn oncologyShruthi Shivdas
 

Was ist angesagt? (19)

Hereditary Cancer Syndrome
Hereditary Cancer SyndromeHereditary Cancer Syndrome
Hereditary Cancer Syndrome
 
Kimberly Glass, Network model - Ovarian Cancer, fged_seattle_2013
Kimberly Glass, Network model - Ovarian Cancer, fged_seattle_2013Kimberly Glass, Network model - Ovarian Cancer, fged_seattle_2013
Kimberly Glass, Network model - Ovarian Cancer, fged_seattle_2013
 
HEREDITARY BREAST and OVARY CANCER [HBOC] SYNDROME, Dr BUI DAC CHI.
HEREDITARY BREAST and OVARY CANCER [HBOC] SYNDROME, Dr BUI DAC CHI.HEREDITARY BREAST and OVARY CANCER [HBOC] SYNDROME, Dr BUI DAC CHI.
HEREDITARY BREAST and OVARY CANCER [HBOC] SYNDROME, Dr BUI DAC CHI.
 
Use of Autoantibodies to detect the onset of breast cancer
Use of Autoantibodies to detect the onset of breast cancerUse of Autoantibodies to detect the onset of breast cancer
Use of Autoantibodies to detect the onset of breast cancer
 
Stefano Volinia, miRNA Signature - Breast Cancer, fged_seattle_2013
Stefano Volinia, miRNA Signature - Breast Cancer, fged_seattle_2013Stefano Volinia, miRNA Signature - Breast Cancer, fged_seattle_2013
Stefano Volinia, miRNA Signature - Breast Cancer, fged_seattle_2013
 
Prophylaxis and early diagnosis of breast cancer
Prophylaxis and early diagnosis of breast cancerProphylaxis and early diagnosis of breast cancer
Prophylaxis and early diagnosis of breast cancer
 
Molecular profiling in breast cancer
Molecular profiling in breast cancerMolecular profiling in breast cancer
Molecular profiling in breast cancer
 
Cancer genetics [autosaved]
Cancer genetics [autosaved]Cancer genetics [autosaved]
Cancer genetics [autosaved]
 
Gene expression profiling in breast carcinoma
Gene expression profiling in breast carcinomaGene expression profiling in breast carcinoma
Gene expression profiling in breast carcinoma
 
Molecular profiling in breast cancer
Molecular profiling in breast cancerMolecular profiling in breast cancer
Molecular profiling in breast cancer
 
Fibromatosis
FibromatosisFibromatosis
Fibromatosis
 
Breast Cancer: A focus on BRCA Mutations.
Breast Cancer: A focus on BRCA Mutations.Breast Cancer: A focus on BRCA Mutations.
Breast Cancer: A focus on BRCA Mutations.
 
Ca breast molecular biology
Ca breast molecular biology Ca breast molecular biology
Ca breast molecular biology
 
14 fast vol 14
14 fast vol 1414 fast vol 14
14 fast vol 14
 
BRCA – IMPORTANCE IN HEREDITARY BREAST & OVARIAN CANCER by Dr Sharda Jain
BRCA – IMPORTANCE IN HEREDITARY  BREAST & OVARIAN CANCER by Dr Sharda Jain BRCA – IMPORTANCE IN HEREDITARY  BREAST & OVARIAN CANCER by Dr Sharda Jain
BRCA – IMPORTANCE IN HEREDITARY BREAST & OVARIAN CANCER by Dr Sharda Jain
 
Brca2 mutation and their influence to cancer
Brca2 mutation and their influence to cancerBrca2 mutation and their influence to cancer
Brca2 mutation and their influence to cancer
 
CCO Rational Options in Breast Cancer : How Molecular Understanding Informs T...
CCO Rational Options in Breast Cancer : How Molecular Understanding Informs T...CCO Rational Options in Breast Cancer : How Molecular Understanding Informs T...
CCO Rational Options in Breast Cancer : How Molecular Understanding Informs T...
 
Immuno histo chemistry in gyn oncology
Immuno histo chemistry in gyn oncologyImmuno histo chemistry in gyn oncology
Immuno histo chemistry in gyn oncology
 
DrTerespolsky
DrTerespolskyDrTerespolsky
DrTerespolsky
 

Ähnlich wie Breast cancer research

Pathology+of+breast+carcinoma+fsm.ac.fj
Pathology+of+breast+carcinoma+fsm.ac.fjPathology+of+breast+carcinoma+fsm.ac.fj
Pathology+of+breast+carcinoma+fsm.ac.fjshabeel pn
 
Breast pathology 2
Breast pathology 2Breast pathology 2
Breast pathology 2Prasad CSBR
 
All in the Family: Hereditary Risk for Gynecologic Cancer
All in the Family: Hereditary Risk for Gynecologic CancerAll in the Family: Hereditary Risk for Gynecologic Cancer
All in the Family: Hereditary Risk for Gynecologic Cancerbkling
 
Breast Cancer And Ovarian Cysts
Breast Cancer And Ovarian CystsBreast Cancer And Ovarian Cysts
Breast Cancer And Ovarian CystsSerena Hijazeen
 
Precision Medicine and its potential in Cancer management & treatment.pptx
Precision Medicine and its potential in Cancer management & treatment.pptxPrecision Medicine and its potential in Cancer management & treatment.pptx
Precision Medicine and its potential in Cancer management & treatment.pptxGunjitSetia1
 
Carcinoma breast and its management (1).pptx
Carcinoma breast and its management (1).pptxCarcinoma breast and its management (1).pptx
Carcinoma breast and its management (1).pptxDr Sajad Nazir
 
Cancer susceptibility syndromes dr. varun
Cancer susceptibility syndromes dr. varunCancer susceptibility syndromes dr. varun
Cancer susceptibility syndromes dr. varunVarun Goel
 
Ovarian cancer abbey
Ovarian cancer abbeyOvarian cancer abbey
Ovarian cancer abbeyddcoberley
 
Am 7.15 shulman
Am 7.15 shulmanAm 7.15 shulman
Am 7.15 shulmanplmiami
 
Genesilencing in Breast Cancer
Genesilencing in Breast CancerGenesilencing in Breast Cancer
Genesilencing in Breast CancerTamil Jothi
 
Gene silencing in Breast cancer
Gene silencing in Breast cancer Gene silencing in Breast cancer
Gene silencing in Breast cancer Santhi Dasari
 
Breast Carcinoma pakistan.pptx
Breast Carcinoma pakistan.pptxBreast Carcinoma pakistan.pptx
Breast Carcinoma pakistan.pptxJawad Awan
 

Ähnlich wie Breast cancer research (20)

Pathology+of+breast+carcinoma+fsm.ac.fj
Pathology+of+breast+carcinoma+fsm.ac.fjPathology+of+breast+carcinoma+fsm.ac.fj
Pathology+of+breast+carcinoma+fsm.ac.fj
 
Breast pathology 2
Breast pathology 2Breast pathology 2
Breast pathology 2
 
All in the Family: Hereditary Risk for Gynecologic Cancer
All in the Family: Hereditary Risk for Gynecologic CancerAll in the Family: Hereditary Risk for Gynecologic Cancer
All in the Family: Hereditary Risk for Gynecologic Cancer
 
Hereditary Cancer Predisposition
Hereditary Cancer PredispositionHereditary Cancer Predisposition
Hereditary Cancer Predisposition
 
Breast Cancer And Ovarian Cysts
Breast Cancer And Ovarian CystsBreast Cancer And Ovarian Cysts
Breast Cancer And Ovarian Cysts
 
Brca acog 2017
Brca acog 2017Brca acog 2017
Brca acog 2017
 
Precision Medicine and its potential in Cancer management & treatment.pptx
Precision Medicine and its potential in Cancer management & treatment.pptxPrecision Medicine and its potential in Cancer management & treatment.pptx
Precision Medicine and its potential in Cancer management & treatment.pptx
 
BRCA ONCOLOGY.ppt
BRCA ONCOLOGY.pptBRCA ONCOLOGY.ppt
BRCA ONCOLOGY.ppt
 
BRCA ONCOLOGY.ppt
BRCA ONCOLOGY.pptBRCA ONCOLOGY.ppt
BRCA ONCOLOGY.ppt
 
Breast cancer ppt
Breast cancer  pptBreast cancer  ppt
Breast cancer ppt
 
Carcinoma breast and its management (1).pptx
Carcinoma breast and its management (1).pptxCarcinoma breast and its management (1).pptx
Carcinoma breast and its management (1).pptx
 
Cancer susceptibility syndromes dr. varun
Cancer susceptibility syndromes dr. varunCancer susceptibility syndromes dr. varun
Cancer susceptibility syndromes dr. varun
 
Cancer genetics
Cancer geneticsCancer genetics
Cancer genetics
 
Breast cancer risk factors
Breast cancer risk factors Breast cancer risk factors
Breast cancer risk factors
 
Ovarian cancer abbey
Ovarian cancer abbeyOvarian cancer abbey
Ovarian cancer abbey
 
Am 7.15 shulman
Am 7.15 shulmanAm 7.15 shulman
Am 7.15 shulman
 
Genesilencing in Breast Cancer
Genesilencing in Breast CancerGenesilencing in Breast Cancer
Genesilencing in Breast Cancer
 
Gene silencing in Breast cancer
Gene silencing in Breast cancer Gene silencing in Breast cancer
Gene silencing in Breast cancer
 
Breast Carcinoma pakistan.pptx
Breast Carcinoma pakistan.pptxBreast Carcinoma pakistan.pptx
Breast Carcinoma pakistan.pptx
 
Bcancer
BcancerBcancer
Bcancer
 

Breast cancer research

  • 1. PREVELENCE OF CANCER ASSOCIATED GENES IN BREAST CANCER PATIENTS IN THE HOSPITAL BASED STUDY FROM SOUTHERN ASSAM Presented By Jagadish Hansa Biotechnology dept. Assam University, Silchar
  • 2. What is breast cancer ?? Umberto Veronesi said if India does not put in place a vigorous mechanism for early detection and an awareness building exercise, then India will have more breast cancer patient as compare to other part of world in 2020. Types of undesired cell growth in breast:- Fibroadenoma Cyst Abscess Fibrocystic disease Tumor TUMOR
  • 3. Symptoms of breast cancer  Change in nipple  Change in direction of nipple  Eczematous changes of nipple  Presence of a lump or thickening  Persistent discomfort and pain  Change in nipple discharge  Change in appearance of moles
  • 4. FACTORS EFFECTING BREAST Simply being a woman is the main risk factor for Developing breast cancer. Two types:- sporadic and hereditary breast cancer. Hereditary cancer is by BRCA1 and BRCA2 gene. Commonest cause of death for woman (35-55yr). Age Family History Genetic Factors Reproductive History Radiation Race Menstrual Treatment with History DES
  • 5. BRCA1 - location  Localized to the long arm of chromosome 17q21.  Distributed over 100,000 base pairs of DNA.  24 exons (22 coding + 2 non-coding) which encode a protein that is 1,863 aa in length.  BRCT (C-terminal of BRCA) domain – Consists of 2 conserved BRCT repeats~90-100 amino acids long.  N-terminal – ring-finger domain where Bard1 protein bind.
  • 6. BRCA2  Localized to chromosome 13q12-13.  27 encoding exons distributed over roughly 70 kb of genomic DNA.  The exons encode a known sequence of 3418 aa length.  Carriers also have increased risks of pancreatic, prostate, laryngeal, and ocular cancers.
  • 7. Normal function!!!  BRCA 1 and BRCA 2 – Known as breast and ovarian cancer susceptibility genes – Tumor suppressor genes  regulate the cycle of cell division by keeping cells from growing and dividing too rapidly or in an uncontrolled way  inhibit the growth of cells that line the milk ducts in the breast – Involved in many other functions including control of DNA replication and damage repair
  • 8. Abnormal behaviour of BRCA genes BRCA-1  Germline mutations within BRCA1 predispose carriers (heterozyg- otes) to early onset breast and 80% risk of breast cancer.  Over 100 different mutations are associated with the BRCA1.  Three main anomalies account for approx. 19% of the mutations:- 1) 185delAG in codon 23, 2) 5382insC on codon 1756, 3) 4184del4 in codon 1355.  Mutations found at the 5’ end increased risk of ovarian cancer. BRCA-2  BRCA2 mutations confer higher risk of male breast cancer.  One mutation occur frequently: 6174delT  Similar statistics for BRCA2 carriers, but later age of onset and lead to other tumors: gastric, colon, pancreatic, prostate, and melanoma
  • 9.
  • 10. Thank you all for your kind attention

Hinweis der Redaktion

  1. Fibroadenomas are fibrous, benign (noncancerous) growths in breast tissue. These growths are solid, usually painless lumps that are not attached to any structures in the breast. A fibroadenoma is usually removed surgically, using a local anesthetic. A cyst is a fluid-filled sac. The cause of breast cysts is unknown. In the vast majority of cases, cysts are not harmful, although they may cause pain. Cysts disappear sometimes by themselves, or your doctor may draw out the fluid with a needle. A breast abscess is a collection of pus, resulting from an infection. Symptoms may include tenderness and inflammation. Antibiotics are prescribed to treat the infection, and your doctor may drain the pus. Fibrocystic breast disease is a common condition characterized by an increase in the fibrous and glandular tissues in the breasts, which results in small, nodular cysts, noncancerous lumpiness, and tenderness. Although called a "disease," this condition is not a disease. There is no specific treatment for fibrocystic disease. Treatment of the cysts may be all that is needed (see Cysts above). A tumor that is precancerous or cancerous usually shows up as a white area on a mammogram even before it can be felt. In cases where the tumor is cancerous, it may appear as a white area with radiating arms. A cancerous tumor may have no symptoms or may cause swelling, tenderness, discharge from the nipple or indentation of the nipple, or a dimpled appearance in the skin over the tumor (see inset). A breast biopsy is helpful in determining whether a mass is cancerous.
  2. Let’s talk about the most common risk factors that cannot be changed. Besides being a woman, you are at risk As you get older If you or close blood relatives have had or have this disease. A woman with breast cancer has 3 to 4 times a greater chance of developing a new cancer. Depending on your race: we talked before that white women are more frequently diagnosed with breast cancer than black women. But black women die more of this disease. Asian, Hispanic, and American Indian women are at lower risk. Treatment w/ DES (Diethylstilbestrol)- Between 1940 and 1960, some pregnant women were given DES to lower their chances of miscarriage. Recent studies show that these women have a 35% increased risk of getting breast cancer. Radiation: women who have had chest radiation treatment have a greater risk of breast cancer. Genetic factors: about 1 case of breast cancer in 10 is linked to changes/mutations in certain genes. Menstrual history: women having her menstrual periods before 12 years of age or who went through menopause after age 50 have a slightly higher risk. Reproductive history: women that have no children or who have their first child after 30 have a 40% higher risk.